The Feinstein Institute for Medical Research is working with the University of Notre Dame on biomedical research projects, joint conferences and academic exchange. The alliance will focus research efforts on:
- sepsis, the leading cause of death from infection in the world and the costliest condition for US hospitals;
- bioelectronic medicine, devices that stimulate nerves to treat disease; and
- development of tools and methods for exosome biology, which has broad implications for neurological diseases such as Alzheimer’s and Parkinson’s.
The two organizations will work together on research and joint publication of results, share scientific materials and publications, offer students an exchange program and cooperate in commercializing inventions and intellectual properties.
The Feinstein Institute and the University of Notre Dame are also partners in the Cleveland Clinic Health Care Innovation Alliance. This national network combines efforts in research, clinical investigation and technology development/commercialization to help patients.
“Both of our organizations offer unique sets of research skills and capabilities,” said Kevin Tracey, MD, president of the Feinstein Institute. “By working together, we can make advances in addressing serious health challenges.”
Read the next article, Magnet: LIJ Achieves Gold Standard for Nursing